<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) have been implicated in multidrug resistance, a phenomenon responsible for the failure of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>However, the underlying mechanisms are still unclear </plain></SENT>
<SENT sid="2" pm="."><plain>In our study, we established two <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-resistant <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines displaying some <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> characteristics </plain></SENT>
<SENT sid="3" pm="."><plain>Oct4 overexpression was observed in these two lines </plain></SENT>
<SENT sid="4" pm="."><plain>We performed Oct4 knock down by lentiviral vector-mediated specific shRNA </plain></SENT>
<SENT sid="5" pm="."><plain>Knockdown <z:mp ids='MP_0006042'>increased apoptosis</z:mp>, decreased <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> marker expression and weakened tumorigenicity in drug-resistant cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, we show that these events can be at least in part attributed to the STAT3/Survivin pathway </plain></SENT>
</text></document>